← back to search

Birgitta Sander

Karolinska University Hospital · SE
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Folate and B Vitamins Research, Chronic Lymphocytic Leukemia Research, and Genetic and Kidney Cyst Diseases.
h-index
48
citations
9,228
works
401
NIH funding
primary concept
Medicine
email

Recent publications

Molecular and clinical presentation of <i>UBA1</i>-mutated myelodysplastic syndromes
Blood 2024cited by 44position: middledoi
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
Leukemia 2023cited by 26position: middledoi
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
iScience 2023cited by 24position: middledoi
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
Leukemia & lymphoma/Leukemia and lymphoma 2023cited by 2position: middledoi
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood 2022cited by 1,450position: middledoi
Outcomes of relapsed/refractory diffuse large B‐cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population‐based study of 736 patients
British Journal of Haematology 2022cited by 41position: middledoi
Genomic characterization of lymphomas in patients with inborn errors of immunity
Blood Advances 2022cited by 38position: middledoi
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
Blood Advances 2022cited by 34position: middledoi
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2022cited by 24position: firstdoi
RNA-Editing-Initiated MAVS Signaling is a Key Epitranscriptomic Alteration in Human B Cell Lymphoma
SSRN Electronic Journal 2021cited by 1position: middledoi
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Journal of Clinical Oncology 2019cited by 248position: middledoi
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
Haematologica 2017cited by 48position: middledoi
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent <i>CARD11</i> mutations
Oncotarget 2016cited by 138position: middledoi
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
British Journal of Haematology 2016cited by 69position: middledoi
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
The Journal of Experimental Medicine 2015cited by 99position: middledoi
The heterogeneity of follicular lymphomas: from early development to transformation
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2015cited by 42position: middledoi
The presence of mast cell clonality in patients with unexplained anaphylaxis
Clinical & Experimental Allergy 2014cited by 81position: middledoi
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Haematologica 2014cited by 69position: firstdoi
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Oncogene 2014cited by 64position: middledoi
Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Cancer Research 2012cited by 251position: middledoi
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Blood 2012cited by 163position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Björn E. Wahlin · 4 papers (2014–2023)Qiang Pan‐Hammarström · Karolinska Institutet3 papers (2016–2023)Gunilla Enblad · Science for Life Laboratory3 papers (2021–2023)Eva Kimby · Karolinska University Hospital3 papers (2012–2023)Huilai Zhang · Tianjin Medical University Cancer Institute and Hospital3 papers (2016–2023) · 2 papers (2012–2014)Weicheng Ren · Karolinska Institutet2 papers (2021–2023)Mattias Berglund · Cancer Genetics (United States)2 papers (2021–2023)German Ott · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology2 papers (2014–2015) · 2 papers (2021–2023)Harald Holte · Oslo Cancer Cluster2 papers (2016–2023)Marianne Brodtkorb · University of Oslo2 papers (2016–2023)Xiaofei Ye · Karolinska Institutet2 papers (2021–2023)Ole Christian Lingjærde · University of Oslo2 papers (2016–2023)Karin E. Smedby · Karolinska University Hospital2 papers (2022–2023)Andreas Rosenwald · University of Bonn2 papers (2014–2023)Elı́as Campo · Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer2 papers (2015–2022)Randy D. Gascoyne · BC Cancer Agency2 papers (2014–2014)Rose‐Marie Amini · Science for Life Laboratory2 papers (2021–2023)Kristina Sonnevi · Karolinska Institutet2 papers (2022–2023)